Loading...
XSHG600713
Market cap844mUSD
Jan 09, Last price  
4.77CNY
1D
-0.83%
1Q
0.85%
Jan 2017
-40.00%
Name

NanJing Medical Company Limited

Chart & Performance

D1W1MN
XSHG:600713 chart
P/E
10.71
P/S
0.12
EPS
0.45
Div Yield, %
9.50%
Shrs. gr., 5y
4.92%
Rev. gr., 5y
11.35%
Revenues
53.59b
+6.71%
5,259,717,8906,229,685,3566,827,703,5929,344,858,35111,396,288,05114,025,514,49515,337,627,18617,171,694,21618,024,220,36718,737,790,38122,075,780,80824,813,087,31826,720,500,72827,473,449,17431,303,046,29337,155,742,31939,817,363,61145,123,195,14450,221,563,81353,589,664,728
Net income
578m
-3.00%
2,401,80918,354,45718,583,88446,679,85930,334,90046,241,5479,373,643010,820,43238,680,653128,880,146156,724,461180,271,837239,271,476264,293,782346,920,157376,413,112505,182,814595,667,803577,825,648
CFO
1.91b
16,262,511165,571,861161,314,45981,080,2454,326,55420,216,792119,076,8420168,168,3970000187,697,61601,003,954,5760695,330,71701,906,405,193
Dividend
Jun 28, 20240.16 CNY/sh
Earnings
May 30, 2025

Profile

NanJing Pharmaceutical Company Limited engages pharmaceutical wholesale and retail businesses in China. It also operates approximately 510 pharmacy retail stores and an e-commerce platform. The company was founded in 1951 and is based in Nanjing, China.
URL
https://www.njyy.com/
IPO date
Jul 01, 1996
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
53,589,665
6.71%
50,221,564
11.30%
Cost of revenue
50,913,628
48,224,967
Unusual Expense (Income)
NOPBT
2,676,037
1,996,596
NOPBT Margin
4.99%
3.98%
Operating Taxes
265,259
190,092
Tax Rate
9.91%
9.52%
NOPAT
2,410,777
1,806,504
Net income
577,826
-3.00%
595,668
17.91%
Dividends
(587,942)
(157,059)
Dividend yield
9.38%
2.45%
Proceeds from repurchase of equity
(165)
BB yield
0.00%
Debt
Debt current
6,873,130
3,284,882
Long-term debt
2,355,821
2,428,119
Deferred revenue
293,170
Other long-term liabilities
352,473
1
Net debt
6,857,372
3,096,717
Cash flow
Cash from operating activities
1,906,405
CAPEX
(158,217)
Cash from investing activities
(153,049)
Cash from financing activities
(1,179,300)
466,621
FCF
(1,681,467)
1,431,204
Balance
Cash
2,371,579
2,327,196
Long term investments
289,089
Excess cash
105,206
Stockholders' equity
4,462,953
4,553,018
Invested Capital
16,717,328
12,225,363
ROIC
16.66%
15.22%
ROCE
16.01%
16.12%
EV
Common stock shares outstanding
1,292,365
1,254,037
Price
4.85
-5.27%
5.12
4.28%
Market cap
6,267,970
-2.38%
6,420,672
25.54%
EV
13,945,074
10,212,416
EBITDA
2,946,433
2,257,070
EV/EBITDA
4.73
4.52
Interest
544,887
332,902
Interest/NOPBT
20.36%
16.67%